A new study suggests that certain drugs used to treat enlarged prostate may also reduce the risk of developing dementia with Lewy bodies (DLB). This...
Vous n'êtes pas connecté
WEDNESDAY, June 19, 2024 -- Men taking α-1 adrenergic receptor antagonists terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) seem to have a lower risk for dementia with Lewy bodies (DLB), according to a study published online June 19 in...
A new study suggests that certain drugs used to treat enlarged prostate may also reduce the risk of developing dementia with Lewy bodies (DLB). This...
WEDNESDAY, June 20, 2024 -- Prostate medications might help reduce the risk of a specific type of dementia, a new study suggests. People were less...
WEDNESDAY, June 26, 2024 -- For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis...
FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy...
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital...
MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a...
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study...
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...
A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to...
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study...